NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1040210116

Registered date:25/12/2021

Retrospective multicenter clinical study of risk factors for cetuximab-related infusion reaction in Japanese patients

Basic Information

Recruitment status Not Recruiting
Health condition(s) or Problem(s) studiedColorectal Cancer, Head and Neck Cancer
Date of first enrollment31/01/2022
Target sample size244
Countries of recruitment
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe exploratory factor analysis of the risk of cetuximab-related infusion reaction
Secondary Outcomethe rate of cetuximab-related infusion reaction the percentage of infusion reaction onsets according to adverse event-grades the percentage of medical interventions according to adverse event-grades

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
GenderBoth
Include criteriaOver 20 years old,Japanese, the first administration of cetuximab with chemotherapy or alone
Exclude criteriaThe patients who have allergic reaction during chemotherapy administration on the same day

Related Information

Contact

Public contact
Name Chiharu Onoda
Address 1000 Dohara,Yaizu,Shizuoka Shizuoka Japan 425-8505
Telephone +81-54-623-3111
E-mail chiharu.onoda@hospital.yaizu.shizuoka.jp
Affiliation Yaizu City Hospital
Scientific contact
Name Chiharu Onoda
Address 1000 Dohara,Yaizu,Shizuoka Shizuoka Japan 425-8505
Telephone +81-54-623-3111
E-mail chiharu.onoda@hospital.yaizu.shizuoka.jp
Affiliation Yaizu City Hospital